Is Azvudine Comparable to Nirmatrelvir-Ritonavir in Real-World Efficacy and Safety for Hospitalized Patients with COVID-19? A Retrospective Cohort Study

INTRODUCTION: Azvudine and nirmatrelvir-ritonavir are more extensively used to treat COVID-19 in China due to their earlier approval by the National Medical Products Administration. However, there has been a scarcity of research directly comparing the clinical outcomes between azvudine and nirmatrel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qinqin, Zheng, Bei, Han, Bing, Feng, Pinpin, Xia, Zhongni, Jiang, Hong, Ying, Yin, Zhu, Jun, Fei, Cheng, Xiang, Junlei, Shen, Lingli, Luo, Qiliang, Wu, Yinhuan, Wusiman, Ayiguzhali, Xin, Chuanwei, Zhang, Meiling, Li, Gonghua, Li, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505125/
https://www.ncbi.nlm.nih.gov/pubmed/37486556
http://dx.doi.org/10.1007/s40121-023-00845-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505125/
https://www.ncbi.nlm.nih.gov/pubmed/37486556
http://dx.doi.org/10.1007/s40121-023-00845-7

Ejemplares similares